Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples